These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6940401)

  • 1. Studies on the prevention of glomerulopathy in diabetic rats.
    Rasch R
    Acta Endocrinol Suppl (Copenh); 1981; 242():43-4. PubMed ID: 6940401
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic rats.
    Robles RG; Villa E; Rábano A; Alvarez E; Martínez J; Ruilope LM; Sancho JM
    J Hypertens Suppl; 1993 Dec; 11(5):S208-9. PubMed ID: 8158348
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delay in diabetic late complications--a biological activity of insulin-C-peptide?].
    Gallwitz B; Schmidt WE
    Z Gastroenterol; 1998 Oct; 36(10):925-8. PubMed ID: 9846372
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
    Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental treatment of complications in alloxan diabetic rats with alpha-glucosidase inhibitor from the Chinese medicinal herb ramulus mori.
    Ye F; Shen ZF; Qiao FX; Zhao DY; Xie MZ
    Yao Xue Xue Bao; 2002 Feb; 37(2):108-12. PubMed ID: 12579953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
    Kumar GS; Shetty AK; Salimath PV
    J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.
    El Shazly AH; Mahmoud AM; Darwish NS
    Acta Pharm; 2009 Mar; 59(1):67-73. PubMed ID: 19304559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
    Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
    J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol.
    Kuhad A; Sachdeva AK; Chopra K
    J Agric Food Chem; 2009 Jul; 57(14):6123-8. PubMed ID: 19601660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dietary cholesterol prevents renal tubular lesions in diabetic rats.
    Nutr Rev; 1991 Feb; 49(2):60-2. PubMed ID: 2017324
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats.
    Jeong KH; Lee TW; Ihm CG; Lee SH; Moon JY; Lim SJ
    Am J Nephrol; 2009; 29(3):274-82. PubMed ID: 18812693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of angiotensin II receptor blockage on rats with experimental diabetes nephropathy in early stage].
    Yang L; Fan J; Mi X; Liu X; Xu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):317-9. PubMed ID: 12947726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
    Cocchietto M; Zorzin L; Toffoli B; Candido R; Fabris B; Stebel M; Sava G
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):587-94. PubMed ID: 18926757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
    Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy: HIF activation in prevention of diabetic nephropathy.
    Allison SJ
    Nat Rev Nephrol; 2014 Nov; 10(11):612. PubMed ID: 25247333
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
    Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
    Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.